Ads
related to: von willebrand disease medscapeVisit the official HCP website for a FDA-approved treatment for myelofibrosis. See Important Safety Information and full Prescribing Information, sign up to learn more.
- Dosing & Administration
Learn about dosing and
administration now
- Mechanism of Action
Learn about the MOA
of a new treatment option
- Dosing & Administration
Having Ongoing Symptoms of Severe Active GPA/MPA? Ask Your Doctor About This Treatment. Severe Active GPA/MPA is a Chronic, Progressive Disease, but Treatments Are Available.
Get immediate clinical answers, as well as the latest medical news and perspectives. Join the Top Medical Resource for Physicians Today. Free Membership!
Search results
slideshare.net
- Von Willebrand disease (vWD) is a common, inherited, genetically and clinically heterogeneous hemorrhagic disorder caused by a deficiency or dysfunction of the protein termed von Willebrand factor (vWF). In vWD, defective vWF interaction between platelets and the vessel wall impairs primary hemostasis. [ 1] (See Etiology and Workup.)
People also ask
What is von Willebrand disease?
How is von Willebrand disease diagnosed?
Is von Willebrand disease a congenital bleeding disorder?
Mar 31, 2023 · Von Willebrand disease (vWD) is a common, inherited, genetically and clinically heterogeneous hemorrhagic disorder caused by a deficiency or dysfunction of the protein termed von...
- Clinical Presentation
Clinical Presentation - von Willebrand Disease - Medscape
- Von Willebrand Disease Differential Diagnoses
Von Willebrand Disease Differential Diagnoses - von...
- Questions & Answers
Questions & Answers - von Willebrand Disease - Medscape
- Hemophilia
Hemophilia A is the most common X-linked genetic disease and...
- Treatment & Management
The main treatment options for patients with von Willebrand...
- Workup
Workup - von Willebrand Disease - Medscape
- Pediatric Von Willebrand Disease
Practice Essentials. Although referred to as a single...
- Clinical Presentation
Jan 14, 2024 · March 5, 2008 — The National Heart, Lung, and Blood Institute (NHLBI) has issued the first guidelines for the diagnosis and management of von Willebrand's Disease. These recommendations were posted February 29 on the NHLBI's Web site and appear in the March issue of Haemophilia.
Apr 15, 2024 · The goal of this activity is to discuss the management of patients with von Willebrand Disease (vWD) and examine the emerging role of prophylaxis in the management of vWD. Upon completion of this activity, participants will:
Von Willebrand disease (VWD) represents the most common inherited bleeding disorder, with a prevalence of approximately 1 in 1,000 people. Type 1 disease, assoc A review and commentary on strategies for managing heavy menstrual bleeding, intrapartum use of neuraxial anesthesia, and postpartum hemorrhage in the patient with von Willebrand disease
Ads
related to: von willebrand disease medscapeVisit the official HCP website for a FDA-approved treatment for myelofibrosis. See Important Safety Information and full Prescribing Information, sign up to learn more.
Having Ongoing Symptoms of Severe Active GPA/MPA? Ask Your Doctor About This Treatment. Severe Active GPA/MPA is a Chronic, Progressive Disease, but Treatments Are Available.
